- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
【精品】Pharmaceutical Industry Supply Chain Management66
Pharmaceutical Industry Supply Chain Management The Pharmaceutical Value Chain The pharmaceutical “value chain” is only partially synonymous with the pharmaceutical “supply chain” The “value chain” describes how the addition of knowledge to a specific molecule through transformational processes of RD, pre-clinical, clinical trial, manufacture, marketing and sales activities generates commercial value to a pharma/biotech company The “supply chain” refers to the activities involved with planning, sourcing, manufacturing and distributing your products as it does for any other company There is also a “clinical supply chain” which addresses sourcing and provision of materials to clinical trail investigators It’s still “Source”, “Make” and “Distribute” with “Plan” at the head of each major supply chain domain Pharma Supply Chain Considerations End-user (patient) safety Anti-counterfeiting requirements Product integrity Quality assurance Fraud prevention and detection Electronic signature requirements Records access and retention requirements Product tracking Class 2 pharmaceuticals must carry unique identifiers at the item level “Chain of custody” tracking from manufacturer to distributors and point-of-use (“pedigree” requirements) End-consumers are not the principal product customers CRM doesn’t focus on the patient (yet) Source - End-User Safety Considerations Foremost of all the considerations in the pharma supply chain Are the materials provided by our suppliers safe? Are the products manufactured by our company safe? Are all the products being manufactured reaching the distributors? Are any of our products being adulterated or counterfeited? The supply chain begins with the material supplied for product manufacture Key ingredients need to be covered by Supply Agreements Price, Source, Quantity, Quality, Delivery Quality Agreements Defined Specification Control, Change Control, Complain Resolution Pre-purchase Usability Tests Toxicity Requirements Know where
您可能关注的文档
最近下载
- 多模态数据融合与检索技术教学课件(共4章)第三章多模态数据融合.ppt VIP
- 人教版小学四年级上册数学综合练习题及答案(共八套) .pdf VIP
- 次课对称故障计算仿验.pdf VIP
- 2025及未来5-10年瑶族排毒药浴项目投资价值市场数据分析报告.docx
- 浙江省温州市瓯海中学2025提前招生选拔考试数学试卷 含解析.docx VIP
- (风险管理)商业银行房地产贷款风险管理指引.pdf VIP
- 基于STM32的智能手环设计.docx VIP
- 机修班长年终工作总结.pptx
- (高清版)DB41∕T 1354-2016 人民防空工程标识.pdf VIP
- 湘潭大学会关于发展党员工作的实施细则( .doc VIP
原创力文档


文档评论(0)